ReviewFrontiers in immunology2026
Osteoimmunology: interactions of the bone and immune system.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Osteoimmunology represents an emerging interdisciplinary domain that investigates the reciprocal crosstalk between the skeletal and immune compartments, which serves as the core immunological basis for the pathogenesis of diverse musculoskeletal disorders. This bidirectional communication is facilitated by a shared microenvironment and common molecular mediators. This review systematically synthesizes the regulatory effects of T cells, B cells, and macrophages on bone homeostasis. Their modulatory actions are predominantly executed via proinflammatory cytokines and canonical signaling cascades, with particular emphasis on the RANKL/RANK/OPG axis. In parallel, we highlight that bone lineage cells (e.g., osteoblasts and osteoclasts) are not merely passive targets of immune regulation. Instead, they actively participate in immune cell development and function by secreting cytokines. Together, these interactions form an integrated and dynamic regulatory balance. Under physiological conditions, this finely tuned bone-immune crosstalk maintains bone-immune homeostasis. Its disruption, however, contributes to the pathogenesis of typical musculoskeletal pathologies, including rheumatoid arthritis, osteoporosis, and tumor-associated bone metastasis. Adopting an integrated perspective, this review integrates the shared regulatory mechanisms and microenvironment-dependent features of osteoimmune interactions. It provides a theoretical framework for understanding osteoimmune imbalance in musculoskeletal disorders and for developing precise therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.